6533b7d3fe1ef96bd12601aa

RESEARCH PRODUCT

Physical Activity and Amyloid-β Brain Levels in Elderly Adults with Intact Cognition and Mild Cognitive Impairment

Claire VinelPhilipe De Souto BarretoMarc BonnefoyFrancois CottonPerret BertrandOlivier RouaudPierre PayouxChristophe Cognard

subject

MaleOncologyGerontologyApolipoprotein Emedicine.medical_specialtyMultivariate analysisAmyloidPhysical activityStandardized uptake valueMotor ActivityCognitionAlzheimer Disease[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyInternal medicineHumansMedicineDementiaCognitive DysfunctionAged[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyAmyloid beta-Peptidesmedicine.diagnostic_testbusiness.industryBrainCognitionmedicine.diseaseCross-Sectional StudiesPositron emission tomographyPositron-Emission TomographyFemaleGeriatrics and Gerontologybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

description

Objectives To examine the associations between amyloid-β brain deposition and physical activity (PA) in elderly adults without dementia and to investigate whether the association has a dose-response relationship. Design Cross-sectional study. Setting French community-dwelling people. Participants Elderly adults with normal or mildly impaired cognition (mean age 74.7 ± 4.2; 60.4% female) with available information on current self-reported PA and amyloid-β brain deposition measured using positron emission tomography (PET) using the PET-ligand florbetapir F 18 (n = 268). Measurements A standardized uptake value ratio (SUVR) was obtained for each subject. Participants were divided according to amyloid plaque cortical retention defined according to a SUVR cutoff of 1.10 (SUVR+ vs SUVR−). Results Bivariate and multivariate analyses showed that PA was not significantly associated with SUVR. SUVR+ and SUVR− participants did not differ in terms of volume (continuous PA variables) and levels (categorical PA variables) of PA. PA was not correlated with SUVR in apolipoprotein E e4 carriers or noncarriers. PA was not associated with cognitive function. Conclusion Although PA protects against dementia, there is no solid evidence that this protection involves a reduction in amyloid-β brain deposition. Further studies are needed to determine whether PA (ideally measured at several time-points using objective measures) is involved in the pathophysiology of Alzheimer's disease.

https://doi.org/10.1111/jgs.13530